Puxitatug samrotecan (AZD 8205) is a B7-H4-directed antibody-drug conjugate (ADC) bearing a Topoisomerase I inhibitor (TOP1i) payload. Puxitatug samrotecan improves HR+/HER2- breast cancer[1][2].
Purity:
98.51
CAS Number:
[2760250-80-2]
Target:
Antibody-Drug Conjugates (ADCs),Topoisomerase
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted